{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:22:59Z","timestamp":1794360179168,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.beem.2021.101521","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T15:13:08Z","timestamp":1616080388000},"page":"101521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Epidemiology and mortality of Cushing\u2019s syndrome"],"prefix":"10.1016","volume":"35","author":[{"given":"Osamah A.","family":"Hakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahzada","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Karavitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9522","key":"10.1016\/j.beem.2021.101521_bib1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing\u2019s syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"10.1016\/j.beem.2021.101521_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ecl.2018.02.005","article-title":"Mortality in patients with endogenous Cushing\u2019s syndrome","volume":"47","author":"Javanmard","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.beem.2021.101521_bib3","doi-asserted-by":"crossref","first-page":"101380","DOI":"10.1016\/j.beem.2020.101380","article-title":"Cushing\u2019s syndrome: overview of clinical presentation, diagnostic tools and complications","volume":"34","author":"Barbot","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2021.101521_bib4","first-page":"117","article-title":"Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2021.101521_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/a-1197-6380","article-title":"Mortality of patients with Cushing\u2019s disease","volume":"129","author":"Ntali","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"10.1016\/j.beem.2021.101521_bib6","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing\u2019s syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101521_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11102-014-0631-4","article-title":"Clinical and biochemical manifestations of Cushing\u2019s","volume":"18","author":"Ntali","year":"2015","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.beem.2021.101521_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.beem.2021.101521_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-01888-y","article-title":"Autonomous cortisol secretion in adrenal incidentalomas","volume":"64","author":"Araujo-Castro","year":"2019","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.beem.2021.101521_bib10","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of Endocrinology clinical Practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2021.101521_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-11-1039","article-title":"Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study","volume":"166","author":"Di Dalmazi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2021.101521_bib12","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2021.101521_bib13","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/jbmr.398","article-title":"Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study","volume":"26","author":"Morelli","year":"2011","journal-title":"J\u00a0Bone Miner Res Off J Am Soc Bone Miner Res"},{"issue":"4","key":"10.1016\/j.beem.2021.101521_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing\u2019s disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2021.101521_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2021.101521_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2021.101521_bib17","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2021.101521_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing\u2019s syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2021.101521_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/cen.14014","article-title":"The incidence of endogenous Cushing\u2019s syndrome in the modern era","volume":"91","author":"Wengander","year":"2019","journal-title":"Clin Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2021.101521_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11102-019-00951-1","article-title":"The incidence of Cushing\u2019s disease: a nationwide Swedish study","volume":"22","author":"Ragnarsson","year":"2019","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.beem.2021.101521_bib21","doi-asserted-by":"crossref","first-page":"e1362","DOI":"10.1210\/clinem\/dgaa752","article-title":"Epidemiology and comorbidity of adrenal cushing syndrome: a nationwide cohort study","volume":"106","author":"Ahn","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2021.101521_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2265.2011.04253.x","article-title":"Subclinical Cushing\u2019s syndrome: definition and management","volume":"76","author":"Terzolo","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"12","key":"10.1016\/j.beem.2021.101521_bib23","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2021.101521_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/a-0809-3647","article-title":"Hypercortisolism in newly diagnosed type 2 diabetes: a prospective study of 384 newly diagnosed patients","volume":"51","author":"Steffensen","year":"2019","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101521_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2265.2007.02865.x","article-title":"Screening of Cushing\u2019s syndrome in adult patients with newly diagnosed diabetes mellitus","volume":"67","author":"Reimondo","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2021.101521_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1530\/eje.1.02045","article-title":"Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients","volume":"153","author":"Chiodini","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2021.101521_bib27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","article-title":"Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study","volume":"8","author":"Ebbehoj","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2021.101521_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-130-10-199905180-00015","article-title":"Long-term mortality after transsphenoidal surgery for Cushing disease","volume":"130","author":"Swearingen","year":"1999","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.beem.2021.101521_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","article-title":"The survival and well-being of patients treated for Cushing\u2019s syndrome","volume":"245","author":"Pikkarainen","year":"1999","journal-title":"J\u00a0Intern Med"},{"issue":"3","key":"10.1016\/j.beem.2021.101521_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing\u2019s syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.beem.2021.101521_bib31","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing\u2019s disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2021.101521_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing\u2019s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2021.101521_bib33","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.2011-2957","article-title":"Outcome of Cushing\u2019s disease following transsphenoidal surgery in a single center over 20 years","volume":"97","author":"Hassan-Smith","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2021.101521_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing\u2019s syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2021.101521_bib35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing\u2019s syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2021.101521_bib36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with cushing disease: a Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2021.101521_bib37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2021.101521_bib38","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1210\/clinem\/dgaa774","article-title":"Diabetes, active disease, and afternoon serum cortisol levels predict Cushing\u2019s disease mortality: a cohort study","volume":"106","author":"Rold\u00e1n-Sarmiento","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101521_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:56:07Z","timestamp":1761497767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1521690X21000385"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101521","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and mortality of Cushing\u2019s syndrome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101521"}}